April 28, 2014 — Cardiosonic Ltd. announced CE marking of its TIVUS (therapeutic intravascular ultrasound) ablative ...
One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat ...
April 24, 2013 — Cardiosonic Inc. announced the completion of the first phase of patient enrollment in its first-in-man ...
December 27, 2012 — Cardiosonic Inc., a private developer of technology in the field of renal denervation for the ...